ADHD in the News 2020-10-22

COVID-19, ADHD, and Depression: During ADHD Awareness Month in October, CHADD Shines a Spotlight on the Heightened Impact of the Pandemic on Children and Adults with ADHD

A report published by The Journal of the American Medical Association in September found that symptoms of depression have become three times more prevalent in the United States since the COVID-19 pandemic began...This staggering statistic is of even greater concern for the 17 million children and adults in the US with attention-deficit/hyperactivity disorder (ADHD), who already have a disproportionately higher risk of experiencing depression than their peers.

Children with autism, ADHD have more doctor and hospital visits during infancy

The findings from Duke Health researchers, appearing online Oct. 19 in the journal Scientific Reports, provide evidence that health care utilization patterns in a baby's first year can be gleaned from electronic medical records, serving as a roadmap to provide timely diagnoses and treatments that could improve outcomes and reduce health care costs.

Hypothyroidism in pregnant mothers linked to ADHD in their children

Low levels of key, body-regulating chemicals in mothers during the first three months of pregnancy may interfere with the baby's brain development, a large study shows.

Emerging Treatment Approaches for ADHD

In this video, Psych Congress 2020 cochair Vladimir Maletic, MD, MS, discusses emerging treatments and mechanisms of action for attention deficit/hyperactivity disorder (ADHD). Dr. Maletic is Clinical Professor of Psychiatry, University of South Carolina School of Medicine, Greenville, and spoke at the Psych Congress 2020 psychopharmacology preconference on "ADHD Across the Lifespan: How Neurobiology Informs Our Treatment Choice."

Samuele Cortese, MD, PhD: Precision Medicine Possible in ADHD

Recently, in an article posted in the New England Journal of Medicine, Samuele Cortese, MD, PhD, Professor of Child and Adolescent Psychiatry, University of Southampton, examined the safety and efficacy of medications currently being used to treat ADHD. Cortese said in an interview with HCPLive® the review might be a step toward precision medicine because it will give clinicians a better idea of why a certain medication will work with a certain patient. [video]

Irritability in ADHD May Flag Suicide Risk

Irritability appears to be a potent independent predictor of increased risk for suicidality in children and adolescents with ADHD, Tomer Levy, MD, said at the virtual congress of the European College of Neuropsychopharmacology.

4 Ways to Cope With COVID-19 When Living With ADHD

People with ADHD may be facing disruptive changes in their lives due to the COVID-19 pandemic. These changes may trigger new or worsening symptoms of ADHD or other mental health conditions, such as anxiety or depression. Creating a routine, reframing your symptoms, setting a sleep routine, and socializing digitally may help relieve these symptoms.

Anxiety and Mood Disorders in Children and Adolescents With ADHD

In this video, neurodevelopmental pediatrician Frank Lopez, MD, of Pediatric Neurology PA, Winter Park, Florida, addresses the myth that anxiety and mood disorders do not co-occur with attention-deficit/hyperactivity disorder (ADHD).

Dr. Ari Tuckman: 5 Ways That Businesses Can Help Promote The Mental Wellness Of Their Employees

Let people know that you mean well, even when you sometimes miss the mark, and show them that you are open to feedback. When you step on someone’s toes, acknowledge it, apologize, and make amends, if necessary. Show people that you are approachable....As a part of my series about the “How Business Leaders Are Helping To Promote The Mental Wellness Of Their Employees” I had the pleasure of interviewing Ari Tuckman.